¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17
±³À°ÀÏÀÚ : 2024-04-17
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê

±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
´ã´çÀÚ : °­ÈÆ
¿¬¶ôó : 02-3473-0284  

À̸ÞÀÏ : kda@derma.or.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 21 ½Ã°£ 25ºÐ

¼¼ºÎ¼ö°­·á : 500,000¿ø  

ºñ°í Á¤È¸¿ø 80,000 / ÁØȸ¿ø 40,000 / ºñȸ¿ø 500,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:10~13:30 ÃÊ·Ï Chronic actinic dermatitis: Recent report series, environment-related changes and preceding dermatologic conditions ±è±âÈ£(µ¿¾ÆÀÇ´ë)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 14:00~14:05 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 14:05~14:50 Vitiligo: News on immunopathogenesis and therapeutic perspectives Julien Seneschal(Department of Dermatology University Hospital of Bordeaux Bordeaux France)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 14:50~15:00 Q&A -(-)

±âŸ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 10:30~10:35 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 10:35~11:20 ÃÊ·Ï How MBTI affects successful life ³ªÇضõ(³ªÇضõÁ¤½Å°Ç°­ÀÇÇаú)

Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 11:20~11:30 Q&A -(-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 15:30~15:35 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 15:35~16:20 ÃÊ·Ï Robot and dermatologist¡®s life ¾ÈÇý¹Î(UNIST)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 16:20~16:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 10:20~10:45 ÃÊ·Ï Navigating legal landscapes and future policies in tattoo À̱¤ÁØ(Ŭ¸°¾÷ÇǺΰú)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 10:45~11:05 ÃÊ·Ï Exploring medical tattooing for the treatment of dermatological conditions Ȳ¼ºÁÖ(Ȳ¼ºÁÖÅÐÅÐÇÑÇǺΰú)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 11:05~11:20 ÃÊ·Ï Side effects of tattoos and pigments, and tattoo removal À̽ÃÇü(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 11:20~11:30 Panel discussion ( )

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 13:50~14:04 ÃÊ·Ï Understanding the science behind skin boosters and biostimulators ÇÑÇý¼º(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 14:04~14:18 ÃÊ·Ï Exosomes in atopic dermatitis ¹Ú±Í¿µ(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 14:18~14:32 ÃÊ·Ï Innovations in skin boosting technologies ÀÌ¿µÀÎ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 14:32~14:50 ÃÊ·Ï Integrating skin boosters and biostimulators in clinical practice ±èÈ«¼®(º¸½ºÇǺΰú)

Åä·Ð 04¿ù 17ÀÏ »çÆÄÀ̾î 14:50~15:00 Panel discussion (-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:00~14:05 Overview Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:05~14:20 ÃÊ·Ï Effect of climate on skin and cosmetics Á¤°æÀº(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:20~14:35 ÃÊ·Ï Effect of pollution on skin and cosmetics ±èÇý¼º(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:35~14:50 ÃÊ·Ï Effect of eco-friendly ingredients on skin and cosmetics ¼³Á¤Àº(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:50~15:00 Q&A -(-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 15:30~15:35 Overview Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 15:35~15:50 ÃÊ·Ï Resident memory cells in vitiligo ÃÖÁ¾¿ø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 15:50~16:05 ÃÊ·Ï Resident memory cells in psoriasis ¹éÀ¯»ó(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:05~16:20 ÃÊ·Ï Resident memory cells in atopic dermatitis ½Å±âÇõ(ºÎ»êÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:20~16:30 Q&A -(-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:30~16:35 Overview Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:35~16:50 ÃÊ·Ï Skin infectious diseases related to bacteria from abroad ÀÌ¿ìÁø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:50~17:05 ÃÊ·Ï Skin infectious diseases related to viruses from abroad ¿ìÀ¯¸®(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 17:05~17:20 ÃÊ·Ï Skin infectious diseases related to insects from abroad Àå¿ëÇö(°æºÏÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 17:20~17:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 09:30~09:42 ÃÊ·Ï Biopsy, immunofluorescence ±èº¸¸®(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 09:42~09:54 ÃÊ·Ï Bacterial and fungal examination ÀÌÁö¼ö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 09:54~10:06 ÃÊ·Ï Phototest ³²°æÈ­(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:06~10:18 ÃÊ·Ï Patch and prick tests ÀÌÁ¤¼ö(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:18~10:30 ÃÊ·Ï Dermoscopy ¹Ú»óÇö(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:30~10:42 ÃÊ·Ï Steroids, anti-inflammatory drugs ¼®ÁØ(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:42~10:54 ÃÊ·Ï Immunosuppressants ¿ìÀ¯¸®(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:54~11:06 ÃÊ·Ï Retinoids ÃÖÈÆ(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:06~11:18 ÃÊ·Ï Antihistamines, anti-itch agents ±Ç¼øÈ¿(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:18~11:30 ÃÊ·Ï Antibiotics, antifungals ¼­Çö¹Î(ÇѾçÀÇ´ë)

±âŸ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 09:30~09:35 Overview Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 09:35~09:50 ÃÊ·Ï Recent issues regarding to ocular safety »çÈ£¼®(¿ï»êÀÇ´ë ¾È°ú)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 09:50~10:05 ÃÊ·Ï Practical tips during laser surgery for safety ÀÌÁ¾Èñ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 10:05~10:20 ÃÊ·Ï Laser safety use guidance ¼­Çö¹Î(ÇѾçÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 10:20~10:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 15:30~15:45 ÃÊ·Ï Fundamentals of energy-based devices for pigmentary disorders ÃÖ¼ö¿µ(º¦¿¤ÇǺΰú)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 15:45~16:00 ÃÊ·Ï Upgrade your vitiligo treatment with micropunch grafting ¹èÁ¤¹Î(ÈúÇϿ콺ÇǺΰú)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 16:00~16:15 ÃÊ·Ï Multimodal scar treatment: Basic principles and key techniques ¼Û¸¶°¡·¿(ÁöÀ¯³×ÇǺΰú)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 16:15~16:30 ÃÊ·Ï Botulinum toxin: The essentials from the beginning ¼­Á¾±Ù(¾ÆÄ«µ¥¹ÌÇǺΰú)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 16:30~16:45 ÃÊ·Ï Elevating dermatology: New world of RF and HIFU skin lifting Àü¼ö¿µ(ºû³ª¶óÇǺΰú)

Åä·Ð 04¿ù 17ÀÏ »çÆÄÀ̾î 16:45~17:00 Q&A -(-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 09:30~09:35 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 09:35~09:55 ÃÊ·Ï Terminology in scholarly publication À±Çö¼±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 09:55~10:15 ÃÊ·Ï Evaluation process of scopus and web of science ÀÌ¿µº¹(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 10:15~10:20 Q&A -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 16:30~17:20 ÃÊ·Ï Anti-skin aging strategy Á¤ÁøÈ£(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 17:20~17:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 15:30~15:50 ÃÊ·Ï Function and chemical modulation of autophagy: Its therapeutic application for melanosome degradation ±Ç¿ëÅÂ(¼­¿ïÀÇ´ë ÀÇ°úÇаú)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 15:50~16:10 ÃÊ·Ï Autophagy and melanocytes senescence: A new frontier in photoaging °­Èñ¿µ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 16:10~16:30 ÃÊ·Ï The role of autophagy in the pigmentation ¿À»óÈ£(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 16:30~16:50 ÃÊ·Ï Fibroblasts and autophagy in persistent PIH À̽ÃÇü(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 16:50~17:00 Q&A -(-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:30~13:35 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:35~13:55 ÃÊ·Ï Analyzing uncommon skin cancers in Koreans: EMPD, angiosarcoma, Kaposi¡¯s sarcoma, and DFSP ÇÏ´ë·æ(°æºÏÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:55~14:00 Q&A -(-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 13:30~13:35 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 13:35~13:55 ÃÊ·Ï The interplay between skin and intestinal diseases ¹ÚÇö¼±(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 13:55~14:00 Q&A -(-)

±âŸ 04¿ù 17ÀÏ »çÆÄÀ̾î 17:00~17:05 Overview -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 17:05~17:20 ÃÊ·Ï Inflammatory diseases on hands and feet ±èÁ¤Àº(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 17:20~17:35 ÃÊ·Ï Benign tumors on hands and feet ÇÏ´ë·æ(°æºÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 17:35~17:50 ÃÊ·Ï Malignant tumors on hands and feet ÀÌ¿ìÁø(¿ï»êÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ »çÆÄÀ̾î 17:50~18:00 Q&A -(-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:30~11:35 Introduction -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:35~12:10 ÃÊ·Ï Pioneering early intervention in psoriasis with secukinumab: STEPIn core and mechanistic study ¹ÚÀºÁÖ(ÇѸ²ÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 12:10~12:30 Q&A -(-)

±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 11:30~11:35 Introduction -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 11:35~12:10 ÃÊ·Ï Can we control the emergence of PsA? ¹æöȯ(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 12:10~12:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 14:00~14:25 ÃÊ·Ï Accelerate breakthroughs in atopic dermatitis with abrocitinib ÀüÁöÇö(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 14:25~14:50 ÃÊ·Ï Guidance on leveraging AD treatment to improve outcomes ¿øÁ¾Çö(¿ï»êÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 14:50~15:00 Q&A -(-)

±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 17:00~17:40 ÃÊ·Ï Optimal strategy of long-term AGA treatment with Dutasteride 0.5mg ¹Ú¼ÒÈñ(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 17:40~18:00 Q&A -(-)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-04-18
´ÙÀ½±Û ´ëÇѽɽŻêºÎÀΰúÇÐȸ Á¦17Â÷ Ãá°è ¿öÅ©¼ó : 2024-04-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
333 ¼­¿ï 2018³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2018-09-02 1 3,012 2018-08-08
332 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 433 2018-08-08
331 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 1,003 2018-08-08
330 ÃæºÏ ´ëÇѼҾưúÇÐȸ ÃæºÏ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2018-09-01 0 583 2018-08-08
329 ÀüºÏ Á¦20ȸ ¿µÈ£³²³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ : 2018-09-01 0 648 2018-08-08
328 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¿¬¼¼º´¸® ½ÉÆ÷Áö¿ò : 2018-09-01 0 635 2018-08-08
327 ¼­¿ï ¼øõÇâ´ëÇб³ ¼­¿ïº´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¾ö : 2018-08-31 0 885 2018-08-08
326 ¼­¿ï Á¦ 4ȸ ´ëÇÑÇǺÎÁø±ÕÇÐȸ ¿¬¼ö±³À° : 2018-08-31 0 499 2018-08-08
325 ÀüºÏ Á¦20ȸ ¿µÈ£³²³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ : 2018-08-31 0 1,174 2018-08-08
324 ´ë±¸ ´ë±¸°æºÏ°³¿ø³»°úÀÇ»çȸ ¿¬¼ö°­Á : 2018-08-28 0 1,013 2018-08-08
323 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ºÒ¸éÁõ ÀÎÁöÇൿġ·á : 2018-08-26 0 1,634 2018-08-08
322 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø Á¦ 23ȸ °¡Å縯 ¾È°ú Çмú ½ÉÆ÷Áö¾ö : 2018-08-26 0 1,601 2018-08-08
321 ¼­¿ï ´ëÇÑ°³¿øÀÇÇùÀÇȸ 2018³âµµ Á¦2Â÷ ȸ¿ø¿¬¼ö±³À° : 2018-08-26 0 3,997 2018-08-08
320 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part3, 2ÀÏÂ÷) : 2018-08-26 0 845 2018-08-08
319 ¼­¿ï °í·Á´ëÇб³¾È»êº´¿ø Á¦14ȸ °í·ÁÀÇ´ë ÇǺΰúÇб³½Ç ½ÉÆ÷Áö¾ö ¹× ¿öÅ©¼ó : 2018-08-26 0 692 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷